An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.

Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectivel...

Full description

Bibliographic Details
Main Authors: Claire A Schreiber, Toshie Sakuma, Yoshihiro Izumiya, Sara J Holditch, Raymond D Hickey, Robert K Bressin, Upamanyu Basu, Kazunori Koide, Aravind Asokan, Yasuhiro Ikeda
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-08-01
Series:PLoS Pathogens
Online Access:http://europepmc.org/articles/PMC4526370?pdf=render
_version_ 1818008404847755264
author Claire A Schreiber
Toshie Sakuma
Yoshihiro Izumiya
Sara J Holditch
Raymond D Hickey
Robert K Bressin
Upamanyu Basu
Kazunori Koide
Aravind Asokan
Yasuhiro Ikeda
author_facet Claire A Schreiber
Toshie Sakuma
Yoshihiro Izumiya
Sara J Holditch
Raymond D Hickey
Robert K Bressin
Upamanyu Basu
Kazunori Koide
Aravind Asokan
Yasuhiro Ikeda
author_sort Claire A Schreiber
collection DOAJ
description Adeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors.
first_indexed 2024-04-14T05:29:06Z
format Article
id doaj.art-5782021d39314041814496d41ad5a7ef
institution Directory Open Access Journal
issn 1553-7366
1553-7374
language English
last_indexed 2024-04-14T05:29:06Z
publishDate 2015-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj.art-5782021d39314041814496d41ad5a7ef2022-12-22T02:09:53ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742015-08-01118e100508210.1371/journal.ppat.1005082An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.Claire A SchreiberToshie SakumaYoshihiro IzumiyaSara J HolditchRaymond D HickeyRobert K BressinUpamanyu BasuKazunori KoideAravind AsokanYasuhiro IkedaAdeno-associated viruses (AAV) have evolved to exploit the dynamic reorganization of host cell machinery during co-infection by adenoviruses and other helper viruses. In the absence of helper viruses, host factors such as the proteasome and DNA damage response machinery have been shown to effectively inhibit AAV transduction by restricting processes ranging from nuclear entry to second-strand DNA synthesis. To identify host factors that might affect other key steps in AAV infection, we screened an siRNA library that revealed several candidate genes including the PHD finger-like domain protein 5A (PHF5A), a U2 snRNP-associated protein. Disruption of PHF5A expression selectively enhanced transgene expression from AAV by increasing transcript levels and appears to influence a step after second-strand synthesis in a serotype and cell type-independent manner. Genetic disruption of U2 snRNP and associated proteins, such as SF3B1 and U2AF1, also increased expression from AAV vector, suggesting the critical role of U2 snRNP spliceosome complex in this host-mediated restriction. Notably, adenoviral co-infection and U2 snRNP inhibition appeared to target a common pathway in increasing expression from AAV vectors. Moreover, pharmacological inhibition of U2 snRNP by meayamycin B, a potent SF3B1 inhibitor, substantially enhanced AAV vector transduction of clinically relevant cell types. Further analysis suggested that U2 snRNP proteins suppress AAV vector transgene expression through direct recognition of intact AAV capsids. In summary, we identify U2 snRNP and associated splicing factors, which are known to be affected during adenoviral infection, as novel host restriction factors that effectively limit AAV transgene expression. Concurrently, we postulate that pharmacological/genetic manipulation of components of the spliceosomal machinery might enable more effective gene transfer modalities with recombinant AAV vectors.http://europepmc.org/articles/PMC4526370?pdf=render
spellingShingle Claire A Schreiber
Toshie Sakuma
Yoshihiro Izumiya
Sara J Holditch
Raymond D Hickey
Robert K Bressin
Upamanyu Basu
Kazunori Koide
Aravind Asokan
Yasuhiro Ikeda
An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
PLoS Pathogens
title An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
title_full An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
title_fullStr An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
title_full_unstemmed An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
title_short An siRNA Screen Identifies the U2 snRNP Spliceosome as a Host Restriction Factor for Recombinant Adeno-associated Viruses.
title_sort sirna screen identifies the u2 snrnp spliceosome as a host restriction factor for recombinant adeno associated viruses
url http://europepmc.org/articles/PMC4526370?pdf=render
work_keys_str_mv AT claireaschreiber ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT toshiesakuma ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT yoshihiroizumiya ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT sarajholditch ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT raymonddhickey ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT robertkbressin ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT upamanyubasu ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT kazunorikoide ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT aravindasokan ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT yasuhiroikeda ansirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT claireaschreiber sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT toshiesakuma sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT yoshihiroizumiya sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT sarajholditch sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT raymonddhickey sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT robertkbressin sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT upamanyubasu sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT kazunorikoide sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT aravindasokan sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses
AT yasuhiroikeda sirnascreenidentifiestheu2snrnpspliceosomeasahostrestrictionfactorforrecombinantadenoassociatedviruses